A multicenter, randomized phase III study on neurotoxicity, safety and efficacy of weekly Pacilitaxel infused over 1-h vs. 3-h in patients with advanced solid tumors
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | Undefined/Unknown |
|---|---|
| Journal | European Journal of Cancer Supplements |
| Volume | 1 |
| Issue number | 5 |
| Pages (from-to) | S164 |
| Publication status | Published - 2003 |
ID: 178696564